OK Biotech Co., Ltd. (4155.TW) TAI

Currency In TWD

AD

Valuation

Market Cap2.43B
Enterprise Value3.15B
P/E Ratio19.31
PEG Ratio-0.05
Price/Sales Ratio1.46
Price/Book Ratio0.86
Enterprise/Revenue1.93
Enterprise/EBITDA13.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue1.56B
Revenue/Share10.83
Gross Profit429.25M
EBITDA201.51M
Net Income82.45M
Diluted EPS0.57

Balance Sheet

Total Cash317.98M
Total Cash/Share2.25
Total Debt1.02B
Total Debt/Equity0.4
Current Ratio2.49
Book Value Per Share18.36

Price History

52-Week Change-3.13
52-Week High17.25
52-Week Low12.85
Moving Average 50 Days14.7
Moving Average 200 Days14.41

Statistics

Average Volume454,477
Shares Outstanding144.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield1.94
Payout Ratio0.39
Last Split Factor5510671:5000000
Last Split DateSeptember 06, 2023
AD